Follow-Up with Serum Cyfra 21-1 in Patients with Squamous Cell Carcinomas of the Head and Neck

Publisher： Karger

E-ISSN： 1423-0232|63|3|280-285

ISSN： 0030-2414

Source： Oncology, Vol.63, Iss.3, 2002-10, pp. : 280-285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CYFRA21-1 as a serum tumor marker for follow-up patients with squamous cell lung carcinoma and oropharynx squamous cell carcinoma

By Liu Lei   Liu Bin   Zhu Li-li   Li Yu  

Biomarkers in Medicine, Vol. 7, Iss. 4, 2013-08 ,pp. : 591-599

Future Medicine

Access to resources Recommend Favorite

Serum p53 Autoantibodies in the Follow-Up of Head and Neck Cancer Patients

By  

Oncology, Vol. 59, Iss. 1, 2000-06 ,pp. : 31-35

Karger

Access to resources Recommend Favorite

DDX3 has divergent roles in head and neck squamous cell carcinomas in smoking versus non‐smoking patients

By  

ORAL DISEASES, Vol. 21, Iss. 2, 2015-03 ,pp. : 270-271

John Wiley & Sons Inc

Access to resources Recommend Favorite

Migration-Associated Adhesion Molecules in Squamous Cell Carcinomas of the Head and Neck

By  

Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. : 157-163

Karger

Access to resources Recommend Favorite

Diffusion‐weighted imaging in head and neck squamous cell carcinomas: A systematic review

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 3, 2015-03 ,pp. : 440-448

John Wiley & Sons Inc

Access to resources Recommend Favorite